NZ opens door to better treatment of brain dysfunction

University of Otago scientists in New Zealand (NZ) have opened the door to improved treatment of brain dysfunction which...

July 16, 2021 | Friday | News
Korea develops brain-mimicking interface to study neurological diseases

A research team and collaborators at the Korea Advanced Institute of Science and Technology has revealed a new...

July 15, 2021 | Thursday | News
Australia launches $1.5M vaccine and immunobiology lab

Australia-based Agilex Biolabs has launched its new $1.5M vaccine and immuno-biology laboratory. The facility, the most ...

July 15, 2021 | Thursday | News
Japan explores complex lipid metabolism networks for studying various diseases

Researchers at Keio University, Japan, describe cutting edge mass spectrometry technology that offers unpreced...

July 14, 2021 | Wednesday | News
Australia finds way to stop SARS-CoV-2 replication in infected human cells

Scientists at Australia's Peter Doherty Institute for Infection and Immunity (Doherty Institute) and Peter MacCallu...

July 14, 2021 | Wednesday | News
Genetic link between aging brain and brain cancers found by Israeli scientists

Israeli university- Ben-Gurion University of Negev (BGU) scientists have found that a gene activated in glioblastoma, a ...

July 13, 2021 | Tuesday | News
Servier and Nymirum collaborate to develop RNA-Targeted small molecule therapeutics

Paris-based Servier, a global independent pharmaceutical Group, and Nymirum, a pioneer in RNA-targeted small molecules, ...

July 13, 2021 | Tuesday | News
Hummingbird Bioscience and MD Anderson collaborate to advance innovative immunotherapies

Hummingbird Bioscience, a US and Singapore-based innovative clinical-stage biotech company, and The University of T...

July 13, 2021 | Tuesday | News
NZ-based startup Amaroq Therapeutics secures funding to develop cancer treatments

Amaroq Therapeutics, a new biotech start-up spun out of the University of Otago in New Zealand, with one of the world&rs...

July 12, 2021 | Monday | News
Japan sets COVID-19 drug trials up for success

As scientists continue to search high and low for effective COVID-19 treatments, a new modeling study by Japanese resear...

July 9, 2021 | Friday | News
Korea identifies repurposed drugs for COVID-19 treatment via virtual screening assays

A joint research group from Korea Advanced Institute of Science and Technology (KAIST) and Institut Pasteur Ko...

July 8, 2021 | Thursday | News
NZ uses genetic and mathematical modelling to understand lung disease

Researchers at the University of Auckland, New Zealand are pioneering a new approach to the understanding of Chronic Obs...

July 7, 2021 | Wednesday | News
Australia reveals how immune system reacts to COVID-19 variants

Australian scientists researching how our immune system responds to COVID-19 have revealed that those infected by early ...

July 7, 2021 | Wednesday | News
Singapore explores mindfulness-based sleep therapy to treat insomnia

Researchers from the Centre for Sleep and Cognition at the NUS Yong Loo Lin School of Medicine found mindfulness-based t...

July 6, 2021 | Tuesday | News
S.Korea's Y-Biologics to globalize immuno-oncology therapeutics with French partner

The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre have entered int...

July 6, 2021 | Tuesday | News
Industry-academia collaboration of neuroprotective therapies for glaucoma in China

Arctic Vision, a China-based clinical-stage ophthalmology company focuses on developing innovative therapies for pa...

July 5, 2021 | Monday | News
Scientists propose repurposing anti-malarial drug Mefloquine to fight COVID-19

Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....

July 2, 2021 | Friday | News
Australia invests $180 M in ground-breaking medical research projects

The Australian Government is investing $180 million in ground-breaking medical research projects around Australia to imp...

July 2, 2021 | Friday | News